Endosense Announces Successful Efficacy Results of the First TactiCath(TM) In Vivo Study Targeting Atrial Fibrillation at the Heart Rhythm Society (HRS) Meeting

GENEVA--(BUSINESS WIRE)--Endosense today announces the presentation of novel scientific data as part of the abstract “Novel Radiofrequency Ablation Catheter with Contact Force Sensor Predicts Lesion Size and Incidence of Steam Pop in Canine Model” at the Heart Rhythm Society (HRS) 2007 annual meeting in Denver, USA. Tacticath™, the new Endosense catheter, demonstrated a statistically significant correlation between force and the key characteristics of the lesion: volume, depth, and surface (p<0.001 for each of these parameters). As effective Radio Frequency lesion-making depends critically upon contact, real time assessment of contact force is extremely important. TactiCath™ will bring an accurate measurement and real time control of force at the catheter tip. The lead investigator is Dr Hiroshi Nakagawa, one of the co-investigators is Dr Dipen Shah.

MORE ON THIS TOPIC